Fumagalli, Giorgio Giulio
 Distribuzione geografica
Continente #
NA - Nord America 6.273
AS - Asia 3.698
EU - Europa 2.471
SA - Sud America 772
Continente sconosciuto - Info sul continente non disponibili 459
AF - Africa 97
OC - Oceania 22
Totale 13.792
Nazione #
US - Stati Uniti d'America 6.017
SG - Singapore 1.577
IT - Italia 1.043
CN - Cina 703
BR - Brasile 642
VN - Vietnam 523
RU - Federazione Russa 247
GB - Regno Unito 230
DE - Germania 172
KR - Corea 172
FR - Francia 163
LV - Lettonia 141
HK - Hong Kong 135
CA - Canada 133
BD - Bangladesh 126
ID - Indonesia 120
IN - India 103
FI - Finlandia 91
NL - Olanda 89
AT - Austria 77
IQ - Iraq 50
MX - Messico 50
AR - Argentina 38
JP - Giappone 35
PL - Polonia 30
EC - Ecuador 27
ZA - Sudafrica 27
PK - Pakistan 26
IE - Irlanda 25
JM - Giamaica 22
SE - Svezia 22
AU - Australia 21
ES - Italia 20
TR - Turchia 18
CR - Costa Rica 15
GR - Grecia 15
HU - Ungheria 15
SA - Arabia Saudita 15
UA - Ucraina 14
CL - Cile 13
BE - Belgio 12
JO - Giordania 12
MA - Marocco 12
VE - Venezuela 12
PT - Portogallo 11
CO - Colombia 10
HN - Honduras 10
CH - Svizzera 9
KE - Kenya 9
PH - Filippine 9
TN - Tunisia 9
EG - Egitto 8
PE - Perù 8
PY - Paraguay 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
BO - Bolivia 7
DZ - Algeria 7
ET - Etiopia 6
IL - Israele 6
RS - Serbia 6
UY - Uruguay 6
DK - Danimarca 5
GE - Georgia 5
IR - Iran 5
LB - Libano 5
MY - Malesia 5
OM - Oman 5
AL - Albania 4
BG - Bulgaria 4
PA - Panama 4
SN - Senegal 4
SV - El Salvador 4
CI - Costa d'Avorio 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
EE - Estonia 3
GT - Guatemala 3
KG - Kirghizistan 3
LT - Lituania 3
NI - Nicaragua 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
AM - Armenia 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
GA - Gabon 2
GH - Ghana 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MD - Moldavia 2
NP - Nepal 2
PR - Porto Rico 2
QA - Qatar 2
RO - Romania 2
SC - Seychelles 2
Totale 13.310
Città #
Ashburn 1.011
Singapore 991
San Jose 827
Council Bluffs 484
Columbus 390
Trento 356
Dallas 293
Santa Clara 288
Seoul 168
Phoenix 165
Ho Chi Minh City 158
Los Angeles 145
Riga 141
Moscow 137
Hanoi 133
Hong Kong 130
Hefei 125
Lauterbourg 114
Milan 114
New York 105
Jakarta 94
Nuremberg 78
The Dalles 76
Chicago 71
Buffalo 64
London 63
Beijing 62
São Paulo 62
Washington 62
Redondo Beach 54
Orem 53
North Bergen 51
Rome 50
Da Nang 43
Munich 42
Lappeenranta 40
Boardman 39
Brooklyn 34
Helsinki 33
Salt Lake City 32
Secaucus 31
Amsterdam 30
Atlanta 30
Frankfurt am Main 30
Tokyo 30
Miano 27
Montreal 27
Riverside 27
Vienna 26
Haiphong 25
Warsaw 23
Denver 21
Rio de Janeiro 21
Dublin 20
Guangzhou 20
Tampa 19
Chennai 18
Mesa 18
Philadelphia 18
Toronto 18
Baghdad 17
Paris 17
Belo Horizonte 16
Charlotte 16
Curitiba 16
Mexico City 16
Shanghai 16
Carrboro 15
Mumbai 14
Turku 14
Budapest 13
Houston 13
San Francisco 13
San José 13
Agrolândia 12
Florence 12
Manchester 12
Bassano del Grappa 11
Johannesburg 11
Quito 11
Seattle 11
Biên Hòa 10
Brasília 10
Elk Grove Village 10
Kingston 10
Ottawa 10
Amman 9
Birmingham 9
Bologna 9
Campinas 9
Dhaka 9
Erbil 9
Naples 9
New Delhi 9
Tempe 9
Boston 8
Daiano 8
Greenville 8
Imperia 8
Islington 8
Totale 8.317
Nome #
Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia 296
The Italian guideline on diagnosis and treatment of dementia and mild cognitive impairment 274
The search for a link between autism spectrum disorder and neurodegenerative dementia 269
The efficacy of cognitive stimulation, cognitive training, and cognitive rehabilitation for people living with dementia: a systematic review and meta-analysis 176
Utility of visual rating scales in primary progressive aphasia 174
Tango and physiotherapy interventions in Parkinson’s disease: a pilot study on efficacy outcomes on motor and cognitive skills 154
Parieto-occipital sulcus widening differentiates posterior cortical atrophy from typical Alzheimer disease 152
Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study 146
Mental State Recognition Deficits Linked to Brain Changes in Parkinson's Disease Without Dementia 145
Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia 133
Proteomic analysis reveals distinct cerebrospinal fluid signatures across genetic frontotemporal dementia subtypes 129
MRI visual rating scales in the diagnosis of dementia: Evaluation in 184 post-mortem confirmed cases 125
Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: a genome-wide association study 122
Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia 120
Impairment of episodic memory in genetic frontotemporal dementia: A GENFI study 120
A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia 119
Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference 116
CSF β-amyloid and white matter damage: A new perspective on Alzheimer's disease 116
The inner fluctuations of the brain in presymptomatic Frontotemporal Dementia: The chronnectome fingerprint 113
Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: From biological biomarkers to clinical syndromes 113
Discrepant Views of Apathy in Patients and Caregivers: the Role of Cognitive Deficits in Parkinson's Disease 111
Clinical Heterogeneity in Alzheimer’s Disease: A Possible New Amnesic Phenotype 111
Distinct patterns of brain atrophy in Genetic Frontotemporal Dementia Initiative (GENFI) cohort revealed by visual rating scales 109
Predictor model for mild cognitive impairment in Parkinson’s disease using visual rating scales 108
Aquaporin-4 cerebrospinal fluid levels are higher in neurodegenerative dementia: looking at glymphatic system dysregulation 108
Association of Superficial White Matter Alterations with Cerebrospinal Fluid Biomarkers and Cognitive Decline in Neurodegenerative Dementia 107
Examining empathy deficits across familial forms of frontotemporal dementia within the GENFI cohort 107
Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: A cross-sectional analysis 107
MRI data-driven algorithm for the diagnosis of behavioural variant frontotemporal dementia 106
Predominant right temporal lobe atrophy: Clinical, neuropsychological and structural differences based on amyloid status 105
Temporal order of clinical and biomarker changes in familial frontotemporal dementia 105
The Italian fund for Alzheimer's and other dementias: strategies and objectives to face the dementia challenge 104
Patterns of gray matter atrophy in genetic frontotemporal dementia: results from the GENFI study 104
Early neurotransmitters changes in prodromal frontotemporal dementia: A GENFI study 104
CSF glial markers are elevated in a subset of patients with genetic frontotemporal dementia 101
Cognitive reserve and TMEM106B genotype modulate brain damage in presymptomatic frontotemporal dementia: A GENFI study 101
Anomia is present pre-symptomatically in frontotemporal dementia due to MAPT mutations 101
Analysis of brain atrophy and local gene expression in genetic frontotemporal dementia 100
Amyloid PET imaging and dementias: potential applications in detecting and quantifying early white matter damage 100
Diagnostic accuracy of research criteria for prodromal frontotemporal dementia 99
The CBI-R detects early behavioural impairment in genetic frontotemporal dementia 98
Extending the phenotypic spectrum assessed by the CDR plus NACC FTLD in genetic frontotemporal dementia 98
Faster Cortical Thinning and Surface Area Loss in Presymptomatic and Symptomatic C9orf72 Repeat Expansion Adult Carriers 98
Neuronal pentraxin 2: a synapse-derived CSF biomarker in genetic frontotemporal dementia 97
Word and Picture Version of the Free and Cued Selective Reminding Test (FCSRT): Is There Any Difference? 97
Network structure and transcriptomic vulnerability shape atrophy in frontotemporal dementia 95
Profiling of specific gene expression pathways in peripheral cells from prodromal Alzheimer's disease patients 95
A panel of CSF proteins separates genetic frontotemporal dementia from presymptomatic mutation carriers: a GENFI study 95
Facing the digital divide into a dementia clinic during COVID-19 pandemic: caregiver age matters 95
Comparison of arterial spin labeling registration strategies in the multi-center GENetic frontotemporal dementia initiative (GENFI) 94
Association between enlarged perivascular spaces and cerebrospinal fluid aquaporin-4 and tau levels: report from a memory clinic 94
Conceptual framework for the definition of preclinical and prodromal frontotemporal dementia 93
MiRNA Profiling in Plasma Neural-Derived Small Extracellular Vesicles from Patients with Alzheimer's Disease 93
The role of sex and education in the clinical manifestation and progression of Posterior Cortical Atrophy. 92
Monozygotic Twins with Frontotemporal Dementia Due to Thr272fs GRN Mutation Discordant for Age at Onset 92
Unravelling the Association between Amyloid-PET and Cerebrospinal Fluid Biomarkers in the Alzheimer's Disease Spectrum: Who Really Deserves an A+? 92
Data-driven staging of genetic frontotemporal dementia using multi-modal MRI 91
Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia 91
Differential early subcortical involvement in genetic FTD within the GENFI cohort 90
Teaching NeuroImage: Crowned Dens Syndrome: An Acute Attack of Calcium Pyrophosphate Deposition Disease Mimicking Acute Meningitis 89
Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study 89
Impaired glymphatic system in genetic frontotemporal dementia: a GENFI study 89
Disease-related cortical thinning in presymptomatic granulin mutation carriers 89
The potential of neurovascular modulation with tDCS: an exploratory analysis in older adults with hypertension. 89
Social cognition impairment in genetic frontotemporal dementia within the GENFI cohort 88
Accuracy of the clinical diagnosis of dementia with Lewy bodies (DLB) among the Italian Dementia Centers: a study by the Italian DLB study group (DLB-SINdem) 87
A modified Camel and Cactus Test detects presymptomatic semantic impairment in genetic frontotemporal dementia within the GENFI cohort 87
The Revised Self-Monitoring Scale detects early impairment of social cognition in genetic frontotemporal dementia within the GENFI cohort 87
Education modulates brain maintenance in presymptomatic frontotemporal dementia 86
Cerebellar and subcortical atrophy contribute to psychiatric symptoms in frontotemporal dementia 86
Cognitive composites for genetic frontotemporal dementia: GENFI-Cog 85
Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis: correlation with CSF β-amyloid levels and brain volumes 85
The loss of macular ganglion cells begins from the early stages of disease and correlates with brain atrophy in multiple sclerosis patients 85
Crossing Borders between Frontotemporal Dementia and Psychiatric Disorders: An Updated Overview 84
Modelling the cascade of biomarker changes in GRN-related frontotemporal dementia 84
Brain functional network integrity sustains cognitive function despite atrophy in presymptomatic genetic frontotemporal dementia 84
A Novel Automated Chemiluminescence Method for Detecting Cerebrospinal Fluid Amyloid-Beta 1-42 and 1-40, Total Tau and Phosphorylated-Tau: Implications for Improving Diagnostic Performance in Alzheimer’s Disease 84
Plasma microglial-derived extracellular vesicles are increased in frail patients with Mild Cognitive Impairment and exert a neurotoxic effect 84
Motor symptoms in genetic frontotemporal dementia: developing a new module for clinical rating scales 83
An Automated Toolbox to Predict Single Subject Atrophy in Presymptomatic Granulin Mutation Carriers 82
Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysis 81
Stratifying the Presymptomatic Phase of Genetic Frontotemporal Dementia by Serum NfL and pNfH: A Longitudinal Multicentre Study 80
Behavioral and neurophysiological effects of transcranial direct current stimulation (tDCS) in fronto-temporal dementia 80
Progranulin plasma levels predict the presence of GRN mutations in asymptomatic subjects and do not correlate with brain atrophy: results from the GENFI study 80
Banks of the Superior Temporal Sulcus in Alzheimer's Disease: A Pilot Quantitative Susceptibility Mapping Study 80
Altered plasma protein profiles in genetic FTD - a GENFI study 80
Practice effects in genetic frontotemporal dementia and at-risk individuals: a GENFI study 80
Genetic forms of primary progressive aphasia within the GENetic Frontotemporal dementia Initiative (GENFI) cohort: comparison with sporadic primary progressive aphasia 80
Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration 80
Caregiver Tele-Assistance for Reduction of Emotional Distress during the COVID-19 Pandemic. Psychological Support to Caregivers of People with Dementia: The Italian Experience 80
White matter hyperintensities in progranulin-associated frontotemporal dementia: A longitudinal GENFI study 79
Does cognitive decline influence signing? 79
Frequency and Longitudinal Course of Motor Signs in Genetic Frontotemporal Dementia 78
Cerebral perfusion changes in presymptomatic genetic frontotemporal dementia: A GENFI study 78
miRNA Expression Is Increased in Serum from Patients with Semantic Variant Primary Progressive Aphasia 77
Diogenes syndrome in dementia: a case report 76
Language impairment in the genetic forms of behavioural variant frontotemporal dementia 76
Cerebrospinal Fluid Level of Aquaporin4: A New Window on Glymphatic System Involvement in Neurodegenerative Disease? 75
Longitudinal cerebral perfusion in presymptomatic genetic frontotemporal dementia: GENFI results 75
Alzheimer's Disease Diagnosis: Discrepancy between Clinical, Neuroimaging, and Cerebrospinal Fluid Biomarkers Criteria in an Italian cohort of Geriatric Outputs: A Retrospective Cross-sectional Study 75
Totale 10.375
Categoria #
all - tutte 66.968
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 619
Totale 67.587


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/2023528 0 0 0 50 255 99 26 26 25 5 10 32
2023/2024977 5 12 77 30 78 215 159 91 10 87 68 145
2024/20252.778 62 31 140 473 118 375 67 79 412 342 307 372
2025/20266.814 236 152 749 1.000 870 446 1.220 183 523 727 288 420
2026/20272.695 158 413 831 1.293 0 0 0 0 0 0 0 0
Totale 13.792